BATF alleviates ox-LDL-induced HCAEC injury by regulating SIRT1 expression in coronary heart disease
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306514 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Bei Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Sirtuin 1, Lipoproteins, LDL, Basic-Leucine Zipper Transcription Factors, Coronary Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: minsheng research project of pudong new area science and technology development fund, key discipline group of pudong new area health and health commission, Peak Discipline Construction of Pudong New Area Health Commission.
Abstract (Originalsprache)
Background
Coronary heart disease (CHD) represents a significant global health concern, arising from an intricate interplay between genetic predisposition and environmental influences, with a pivotal involvement of oxidized low-density lipoprotein (ox-LDL) in the pathophysiology of it. We aimed to elucidate the synergistic dynamics of B cell activating transcription factor (BATF) and Sirtuin 1 (SIRT1) in cell injury caused by ox-LDL, reveal potential therapeutic strategies for CHD.
Methods
The GSE42148 dataset was used to analyze Differentially expressed genes (DEGs) to construct a gene co-expression network. Then bioinformatics analysis was performed on key modules to select the BATF gene. In vitro experiments were conducted to investigate the protective impact of BATF against human coronary artery endothelial cells (HCAEC) injury induced by ox-LDL. Further investigations probed the synergistic impact of BATF and SIRT1 modulation on cellular apoptosis and damage in the presence of ox-LDL.
Results
BATF was significantly down-regulated in the CHD sample of the GSE42148 dataset. In vitro assays have proven that BATF alleviates ox-LDL-induced HCAEC injury. Notably, BATF emerged as a pivotal regulator of SIRT1 expression post ox-LDL exposure. Subsequent experiments underscored the interplay between BATF and SIRT1 in mitigating ox-LDL-induced apoptosis and Lactate Dehydrogenase (LDH) activity elevation, highlighting their collaborative role in cellular protection.
Conclusion
The research findings suggested a prospective protective function of BATF in HCAEC injury induced by ox-LDL, likely through the mediation of SIRT1 regulation. These results could offer fresh perspectives on the etiology of CHD and possible treatment avenues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nursing Department, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.
- Department of Cardiovascular Medicine, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.
ORCID-Profile: Can Jin
Förderung
- minsheng research project of pudong new area science and technology development fund
- key discipline group of pudong new area health and health commission
- Peak Discipline Construction of Pudong New Area Health Commission
- Key Sub-specialty of Pudong New Area Health Commission
Zitieren
APA
Tian, B., Ji, J., & Jin, C. (2024). BATF alleviates ox-LDL-induced HCAEC injury by regulating SIRT1 expression in coronary heart disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0306514
Vancouver
Tian B, Ji J, Jin C. BATF alleviates ox-LDL-induced HCAEC injury by regulating SIRT1 expression in coronary heart disease. PLOS ONE. 2024. doi:10.1371/journal.pone.0306514
BibTeX
@article{Tian2024,
author = {Tian, Bei and Ji, Jingyu and Jin, Can},
title = {BATF alleviates ox-LDL-induced HCAEC injury by regulating SIRT1 expression in coronary heart disease},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306514}
}
EUVIMED